NLS Pharmaceutics & Kadimastem Complete Merger Conditions
NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) (“NLS” or the “Company”) and Kadimastem Ltd. (TASE: KDST) (“Kadimastem”) today announced that,...
Duly Health Expands Surgery Access via Valley ASC Partnership
Duly Health and Care, through its Chicagoland medical group, DuPage Medical Group, Ltd., has announced...
Laplace Interventional Completes Trans-Jugular Study, Adds Femoral
Laplace announces two major achievements: successful completion of patient enrollment in its US Early Feasibility...
Cristcot to Present Novel UC Treatment Data at ACG 2025 Meeting
CESSA Phase 3 Clinical Trial Results Earn ACG Presidential Poster Distinction Among Nearly 6,000 Abstracts...
Komodo Health Names Mark Jewett as Chief Marketing Officer
Veteran marketing executive from Microsoft, Tableau, and Informatica to lead marketing and scale Komodo’s AI-first...
Synbio Expands Board, Strengthens Clinical Leadership with Dr. Vatakis
Dr. Vatakis, appointed as Medical Director, brings decades of clinical trial leadership, advancing Synbio’s credibility...